Blog
Csp Posts 18 Percent Revenue Gain in Q3
CSPI (NASDAQ:CSPI), a technology firm specializing in advanced IT solutions and cybersecurity products, released its Q3 FY2025 results on August 14, 2025. The most notable news was an 18% rise in
Lifeward Sales Fall 15%, Miss Forecast
Lifeward (NASDAQ:LFWD), a developer of mobility and rehabilitation medical devices, released its second quarter 2025 earnings results on August 14, 2025. The company reported non-GAAP earnings per
Air Industries Revenue Drops 6.6% in Q2
Air Industries Group (NYSEMKT:AIRI), a supplier of precision components and assemblies for the defense and aerospace industries, released its Q2 2025 earnings report on August 14, 2025. The company
Contango Ore Posts Record Profit in Q2
Contango Ore (NYSEMKT:CTGO), an Alaska-focused gold exploration and production company, posted a record quarter in its earnings release on August 13, 2025. The company reported GAAP earnings per
This Famous Investor Just Bought The Trade Desk After the Stock Plunged. Should Investors Follow Suit?
Shares of The Trade Desk (NASDAQ: TTD) were absolutely obliterated after the adtech company reported its second-quarter earnings and announced the departure of its CFO. The stock fell nearly 40% the
Smith-Midland Revenue Jumps 33% in Q2
Smith-Midland (NASDAQ:SMID), a manufacturer of precast concrete products known for its innovative proprietary barriers and wall systems, reported results on August 14, 2025. The big headline was
Unicycive Posts 65% EPS Gain in Q2
Unicycive Therapeutics (NASDAQ:UNCY), a clinical-stage biotechnology firm focused on kidney disease treatments, released its second-quarter results on August 14, 2025, for the period ended June 30
Oblong Profit Jumps 92 Percent
Oblong (NASDAQ:OBLG), a developer of collaboration technology, reported its second quarter 2025 earnings on August 14, 2025. The most significant news was a steady revenue figure compared to the
MSC Income Fund Posts 22% Gain
MSC Income Fund (NYSE:MSIF), a business development company specializing in private loans and lower middle market investments, reported its second-quarter fiscal 2025 results on August 13, 2025. The
MeiraGTx Sales Jump 1,133 Percent
MeiraGTx Plc (NASDAQ:MGTX), a biotechnology company specializing in gene therapies for neurodegenerative, ocular, and glandular disorders, released its second quarter results on August 14, 2025. The
Cellebrite Begins Its Next Chapter
Here's our initial take on Cellebrite DI's (NASDAQ: CLBT) financial report.
Cellebrite has enjoyed high demand for its digital investigative software, with both government entities and
Sow Good Reports 88 Percent Sales Drop
Sow Good (NASDAQ:SOWG), a freeze-dried snack manufacturer based in Texas, released its second-quarter results on August 14, 2025. The most important headline from the report was a steep decline in
Why the Google Antitrust Ruling Could Deal a Blow to Apple's Profits
Apple (NASDAQ: AAPL) shares have been trending higher lately due to news that has assuaged investor concerns about the impact of recent tariff hikes on profitability. However, there's another
Adagio Medical Posts Narrower Q2 Loss
Adagio Medical (NASDAQ:ADGM), a medical technology company developing treatments for cardiac arrhythmias, released its second quarter 2025 results on August 13, 2025. The company reported no GAAP
Candel Reports 88 Percent Q2 Loss Drop
Candel Therapeutics (NASDAQ:CADL), a clinical-stage biotech developing viral immunotherapies for cancer, released second-quarter results on August 14, 2025, for the period ended June 30. The most
VYNE Reports Narrower Loss in Fiscal Q2
VYNE Therapeutics (NASDAQ:VYNE), a biotechnology company developing new therapies for inflammatory and autoimmune diseases, reported second quarter 2025 results on August 14, 2025. The most
Synergy Chc EPS Jumps 86 Percent in Q2
Synergy Chc (NASDAQ:SNYR), a health and wellness products company known for its brain health and nutritional supplement brands, released its second quarter 2025 results on August 14, 2025. The most
PAVmed Revenue Jumps 513% in Q2
PAVmed (NASDAQ:PAVM), a medical technology innovator focused on minimally invasive diagnostics and digital health devices, published its earnings results on August 14, 2025. The headline news was a
Falcon Profit Jumps 214 Percent
Falcon's Beyond Global (NASDAQ:FBYD), an operator and developer of theme park and experiential entertainment businesses, released its second-quarter results on August 14, 2025. The key headline was
Why Advanced Micro Devices (AMD) Stock Soared Wednesday
Shares of Advanced Micro Devices (NASDAQ: AMD) jumped 5.4% Wednesday. The chip maker and closest competitor of rival Nvidia saw its stock rise after a research note indicated Nvidia may decide to
Is Twilio a Buy, Sell, or Hold After Its Most Recent Earnings Report?
With the stock down more than 20% just since Thursday's release of its second-quarter results, it would be easy to presume the worst of customer-communications technology company Twilio (NYSE: TWLO)
Zoned Properties Sales Jump 35 Percent
Zoned Properties (OTC:ZDPY), a real estate company specialized in cannabis sector properties, reported its second quarter 2025 earnings on August 14, 2025. The most important news from the release
Cocrystal Pharma Narrows Loss in Q2
Cocrystal Pharma (NASDAQ:COCP), a clinical-stage biotech focusing on antiviral drug development, released its second quarter 2025 earnings on August 14, 2025. The company’s report highlighted a
CoreCard Revenue Jumps 28 Percent in Q2
CoreCard (NYSE:CCRD), a provider of financial technology software and services, delivered its second quarter 2025 earnings on August 14, 2025. The main highlight was a surge in both revenue and
Galectin Beats Q2 Loss Estimates
Galectin Therapeutics (NASDAQ:GALT), a clinical-stage biotech firm focused on liver fibrosis and cancer, reported its second quarter 2025 results on August 14, 2025. The most significant news was a